+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Stable Isotope Labeled Biomolecules - Global Strategic Business Report

  • PDF Icon

    Report

  • 169 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106893
The global market for Stable Isotope Labeled Biomolecules was estimated at US$371.1 Million in 2024 and is projected to reach US$517.0 Million by 2030, growing at a CAGR of 5.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Stable Isotope Labeled Biomolecules market.

Global Stable Isotope Labeled Biomolecules Market - Key Trends & Drivers Summarized

What's Driving Growth in Stable Isotope Labeled Biomolecules for Research?

Stable isotope labeled biomolecules-such as ¹³C, ¹5N, ²H labeled amino acids, nucleotides, lipids, and metabolites-are critical tools in proteomics, metabolomics, pharmacokinetics, and tracer studies. Used in mass spectrometry assays, isotope dilution quantification, MRI imaging agents, cell tracing experiments, and metabolic flux analysis. Major end-users include academic labs, pharma R&D, biomanufacturing QC, and petrochemical testing.

Complex workflows-accurate quantification, pathway mapping, quality assurance-depend on access to high-purity labeled standards customized by isotope type and labeling sites. Manufacturers tailor molecules for cell-culture incorporation, internal standardization, and imaging applications. Analytical instrumentation and software advancements in LC-MS/MS and fragment analysis have elevated demand for robust isotopic standards.

Are Production & Customization Platforms Advancing Availability?

Companies are scaling biosynthesis (microbial fermentation with labeled precursors), chemical synthesis, and enzymatic biotransformations to produce high-purity isotopologues. New platforms support site-specific labeling and multiple-label combinations (e.g., dual ¹³C-¹5N), enabling fine-grained metabolic analysis. Automated purification systems using flash chromatography and HPLC increase throughput and reduce costs.

Turn-around optimization-rapid custom batches for pharma timelines-is supported by digital ordering portals and sample delivery tracking. Multi-isotope kits tailored for drug metabolism studies and microbial flux assessments are boosting usage in CROs and biomanufacturers.

Why Are Researchers Integrating These Tools Across Disciplines?

Quantitative biologists and pharmacologists rely on isotope-labeled standards for absolute concentration measurement, clearance profiling, and drug-drug interaction studies. Systems biologists track natural-product biosynthesis pathways using labeled precursors. Crop and environmental researchers use labeled metabolites to trace uptake and transformation in soil-plant systems. Stable isotope liquid tracers in clinical nutritional studies supply non-invasive tracking of absorption and metabolic fate. Regulatory bodies require labeled internal standards for assay validation and batch release tests in QC labs.

What's Powering the Growth in the Stable Isotope Labeled Biomolecules Market?

The growth in the stable isotope labeled biomolecules market is driven by several factors related to research precision, production scalability, and interdisciplinary adoption. Advances in fermentation and chemical-labeling methods are reducing costs and expanding availability of complex isotopologues. Increasing global investment in proteomics, metabolomics, and drug pipelines supports demand for high-quality standards. Customized, short-run synthesis and turnkey standard kits meet CRO, biopharma, and academic timelines. Regulatory expectations for precise quantification in drug and food safety assays support widespread adoption. Additionally, partnerships between instrument vendors and isotope suppliers enable integrated workflows-combining labeled standards with sample prep, analytics, and software-accelerating time-to-result and research quality.

Scope Of Study:

The report analyzes the Stable Isotope Labeled Biomolecules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Type (D Labeled Biomolecules, 15N Labeled Biomolecules, 13C Labeled Biomolecules); End-Use (Scientific Research End-Use, Medical End-Use)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the D Labeled Biomolecules segment, which is expected to reach US$308.0 Million by 2030 with a CAGR of a 5.4%. The 15N Labeled Biomolecules segment is also set to grow at 6.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $97.6 Million in 2024, and China, forecasted to grow at an impressive 5.5% CAGR to reach $82.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Stable Isotope Labeled Biomolecules Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Stable Isotope Labeled Biomolecules Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Stable Isotope Labeled Biomolecules Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Alsachim, BOC Sciences, Cambridge Isotope Laboratories, CDN Isotopes, Cerilliant Corporation and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 37 companies featured in this Stable Isotope Labeled Biomolecules market report include:

  • Alsachim
  • BOC Sciences
  • Cambridge Isotope Laboratories
  • CDN Isotopes
  • Cerilliant Corporation
  • Entegris (IsoSciences)
  • Eurisotop
  • Ionetix
  • IsoFlex
  • IsoLife BV
  • JSC Isotope
  • LGC Standards
  • Lumiprobe
  • Medical Isotopes, Inc.
  • Merck KGaA (Sigma-Aldrich)
  • NIST
  • Nordion (Canada), Inc.
  • Omicron Biochemicals, Inc.
  • PerkinElmer, Inc.
  • Silantes

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Stable Isotope Labeled Biomolecules - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growth in Proteomics and Metabolomics Research Drives Demand for Labeled Biomolecules
  • Rising Adoption of Mass Spectrometry in Life Sciences Propels Use of Stable Isotopes
  • Personalized Medicine and Targeted Drug Development Expand Addressable Research Applications
  • Regulatory Emphasis on Quantitative Bioanalysis Strengthens Business Case for Labeled Standards
  • Increase in Biopharma R&D Budgets Accelerates Demand for High-Purity Stable Isotope Compounds
  • Expansion of Clinical Diagnostics and Biomarker Discovery Spurs Usage in Preclinical Studies
  • Growth in Academic-Industry Collaborations Facilitates Commercial Availability of Custom Molecules
  • Technological Advancements in Labeling Techniques Improve Accuracy and Yield
  • Adoption of Isotope Dilution Techniques in Environmental and Food Testing Broadens Market Scope
  • Outsourcing Trends in Drug Discovery Boost Demand for Third-Party Stable Isotope Services
  • Rising Complexity of Biotherapeutics Drives Requirement for Multi-Isotopic Labeling
  • Globalization of CROs and CDMOs Expands Supply Chain for Labeled Biomolecule Manufacturing
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Stable Isotope Labeled Biomolecules Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Stable Isotope Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Stable Isotope Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for D Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for D Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for D Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for 15N Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for 15N Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for 15N Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for 13C Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for 13C Labeled Biomolecules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for 13C Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Scientific Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Scientific Research End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Scientific Research End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Medical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Medical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Medical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
JAPAN
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
CHINA
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: China 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: China 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
EUROPE
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Stable Isotope Labeled Biomolecules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
FRANCE
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: France 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: France 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
GERMANY
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
UNITED KINGDOM
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
REST OF EUROPE
  • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Rest of Europe Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Rest of Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Rest of Europe Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Rest of Europe 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
ASIA-PACIFIC
  • Stable Isotope Labeled Biomolecules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Asia-Pacific Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Asia-Pacific 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Asia-Pacific Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Asia-Pacific 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
REST OF WORLD
  • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Rest of World Historic Review for Stable Isotope Labeled Biomolecules by Type - D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Rest of World 16-Year Perspective for Stable Isotope Labeled Biomolecules by Type - Percentage Breakdown of Value Sales for D Labeled Biomolecules, 15N Labeled Biomolecules and 13C Labeled Biomolecules for the Years 2014, 2025 & 2030
  • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of World Historic Review for Stable Isotope Labeled Biomolecules by End-Use - Scientific Research End-Use and Medical End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Rest of World 16-Year Perspective for Stable Isotope Labeled Biomolecules by End-Use - Percentage Breakdown of Value Sales for Scientific Research End-Use and Medical End-Use for the Years 2014, 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alsachim
  • BOC Sciences
  • Cambridge Isotope Laboratories
  • CDN Isotopes
  • Cerilliant Corporation
  • Entegris (IsoSciences)
  • Eurisotop
  • Ionetix
  • IsoFlex
  • IsoLife BV
  • JSC Isotope
  • LGC Standards
  • Lumiprobe
  • Medical Isotopes, Inc.
  • Merck KGaA (Sigma-Aldrich)
  • NIST
  • Nordion (Canada), Inc.
  • Omicron Biochemicals, Inc.
  • PerkinElmer, Inc.
  • Silantes

Table Information